Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs28934575
rs28934575
T 0.700 GeneticVariation CLINVAR

dbSNP: rs542027040
rs542027040
0.010 GeneticVariation BEFREE One eccrine gland adenocarcinoma showed allelic loss of 17p and a Cys 176 Arg mutation in the p53 gene. 10660129

2000

dbSNP: rs967461896
rs967461896
0.010 GeneticVariation BEFREE One eccrine gland adenocarcinoma showed allelic loss of 17p and a Cys 176 Arg mutation in the p53 gene. 10660129

2000

dbSNP: rs143752852
rs143752852
0.010 GeneticVariation BEFREE A mutation (T915C: L296P) was found in an adenocarcinoma specimen. 10959094

2000

dbSNP: rs199769221
rs199769221
0.010 GeneticVariation BEFREE Our results show that the Arg117His mutation does not contribute to pathogenesis of a substantial fraction of all pancreatic adenocarcinomas. 11062709

2000

dbSNP: rs1443465532
rs1443465532
0.010 GeneticVariation BEFREE These results demonstrate that P125A endostatin inhibits the angiogenic switch during mammary gland adenocarcinoma tumor progression in the C3(1)/Tag transgenic model. 12209972

2002

dbSNP: rs876658657
rs876658657
0.010 GeneticVariation BEFREE There was no significant association between the hMLH1 -93G-->A genotype and the risk for adenocarcinoma or small cell carcinoma. 15382050

2004

dbSNP: rs587782289
rs587782289
0.010 GeneticVariation BEFREE An SNP, Thr706Ala, in the POLI gene encoding another translesion DNA polymerase was associated with adenocarcinoma and squamous cell carcinoma risk, particularly in individuals of ages < 61 years (OR Ala/Ala + Ala/Thr vs. Thr/Thr = 1.5 and 2.4, respectively). 15609317

2005

dbSNP: rs8305
rs8305
0.010 GeneticVariation BEFREE An SNP, Thr706Ala, in the POLI gene encoding another translesion DNA polymerase was associated with adenocarcinoma and squamous cell carcinoma risk, particularly in individuals of ages < 61 years (OR Ala/Ala + Ala/Thr vs. Thr/Thr = 1.5 and 2.4, respectively). 15609317

2005

dbSNP: rs33917957
rs33917957
MET
0.010 GeneticVariation BEFREE Specific expression of phospho-Met (p-Met) [Y1003] and [Y1230/1234/1235] was seen by immunohistochemistry. p-Met expression was preferentially observed at the NSCLC tumor invasive fronts. c-Met alterations were identified within the semaphorin domain (E168D, L299F, S323G, and N375S) and the juxtamembrane domain (R988C, R988C + T1010I, S1058P, and alternative splice product skipping entire juxtamembrane domain) of a NSCLC cell line and adenocarcinoma tissues. 15735036

2005

dbSNP: rs1057519847
rs1057519847
0.100 GeneticVariation BEFREE The L858R mutation was significantly correlated with gender (women versus men, P < 0.0001), Brinkman index (600 < or = versus 600, P = 0.001), pathologic subtypes (adenocarcinoma versus nonadenocarcinoma, P = 0.007), and differentiation status of the lung cancers (well versus moderately or poorly, P = 0.0439), whereas the deletion mutants were not. 15837743

2005

dbSNP: rs1057519848
rs1057519848
0.100 GeneticVariation BEFREE The L858R mutation was significantly correlated with gender (women versus men, P < 0.0001), Brinkman index (600 < or = versus 600, P = 0.001), pathologic subtypes (adenocarcinoma versus nonadenocarcinoma, P = 0.007), and differentiation status of the lung cancers (well versus moderately or poorly, P = 0.0439), whereas the deletion mutants were not. 15837743

2005

dbSNP: rs121434568
rs121434568
0.100 GeneticVariation BEFREE The L858R mutation was significantly correlated with gender (women versus men, P < 0.0001), Brinkman index (600 < or = versus 600, P = 0.001), pathologic subtypes (adenocarcinoma versus nonadenocarcinoma, P = 0.007), and differentiation status of the lung cancers (well versus moderately or poorly, P = 0.0439), whereas the deletion mutants were not. 15837743

2005

dbSNP: rs1799782
rs1799782
0.010 GeneticVariation BEFREE The associations between the OGG1 Cys/Cys genotype and adenocarcinoma risk and between XRCC1 Arg194Trp polymorphism and lung cancer risk among heavy smokers remained robust given prior probabilities of 25% (FPRP = 0.238) and 10% (FPRP = 0.276), respectively. 15840879

2005

dbSNP: rs746702110
rs746702110
0.010 GeneticVariation BEFREE The associations between the OGG1 Cys/Cys genotype and adenocarcinoma risk and between XRCC1 Arg194Trp polymorphism and lung cancer risk among heavy smokers remained robust given prior probabilities of 25% (FPRP = 0.238) and 10% (FPRP = 0.276), respectively. 15840879

2005

dbSNP: rs25487
rs25487
0.020 GeneticVariation BEFREE This is the first report that the XRCC1 Arg399Gln polymorphism might be important in relation to the risk of adenocarcinoma/adenosquamous carcinoma of the cervix. 15990162

2005

dbSNP: rs1048943
rs1048943
0.010 GeneticVariation BEFREE CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. 16195240

2006

dbSNP: rs125555
rs125555
0.010 GeneticVariation BEFREE For the MBD1 -501delT and Pro(401)Ala polymorphisms, the -501 T/T genotype was associated with a marginal significantly increased risk of adenocarcinoma compared with the -501(-/-) genotype (adjusted OR, 2.07; 95% CI, 1.02-4.20; P = 0.045), and the Pro/Pro genotype was associated with a significantly increased risk of adenocarcinoma compared with the Ala/Ala genotype (adjusted OR, 3.41; 95% CI, 1.21-9.60; P = 0.02). 16284366

2005

dbSNP: rs113488022
rs113488022
0.100 GeneticVariation BEFREE In exon 15, one BRAF mutation (1796 thymine to adenine; V599E) was found in nonsmoking woman with well-differentiated adenocarcinoma. 16376942

2006

dbSNP: rs121913377
rs121913377
0.100 GeneticVariation BEFREE In exon 15, one BRAF mutation (1796 thymine to adenine; V599E) was found in nonsmoking woman with well-differentiated adenocarcinoma. 16376942

2006

dbSNP: rs397517132
rs397517132
0.050 GeneticVariation BEFREE In exon 15, one BRAF mutation (1796 thymine to adenine; V599E) was found in nonsmoking woman with well-differentiated adenocarcinoma. 16376942

2006

dbSNP: rs113488022
rs113488022
0.100 GeneticVariation BEFREE The V600E mutation of the B-RAF gene was analyzed using allele-specific polymerase chain reaction in 79 archival prostatic adenocarcinomas (pT1aG1 to pT3cG3, median Gleason score 6); exons 11 and 15 were sequenced. 16413100

2006

dbSNP: rs121913377
rs121913377
0.100 GeneticVariation BEFREE The V600E mutation of the B-RAF gene was analyzed using allele-specific polymerase chain reaction in 79 archival prostatic adenocarcinomas (pT1aG1 to pT3cG3, median Gleason score 6); exons 11 and 15 were sequenced. 16413100

2006

dbSNP: rs1057519847
rs1057519847
0.100 GeneticVariation BEFREE Two weeks after induction with doxycycline, mice that express the EGFR(L858R) allele show diffuse lung cancer highly reminiscent of human bronchioloalveolar carcinoma and later develop interspersed multifocal adenocarcinomas. 16705038

2006

dbSNP: rs1057519848
rs1057519848
0.100 GeneticVariation BEFREE Two weeks after induction with doxycycline, mice that express the EGFR(L858R) allele show diffuse lung cancer highly reminiscent of human bronchioloalveolar carcinoma and later develop interspersed multifocal adenocarcinomas. 16705038

2006